Common Stock and Warrants (Details Narrative) - USD ($)			1 Months Ended				6 Months Ended	12 Months Ended
	Dec. 13, 2023	Mar. 02, 2022	Dec. 19, 2023	Nov. 29, 2023	Feb. 25, 2022	Apr. 29, 2021	Dec. 31, 2022	Dec. 31, 2023	Jun. 30, 2022	Jun. 30, 2021	Dec. 20, 2023	Feb. 24, 2022
General and administrative							$ 2,658,800	$ 5,417,900	$ 5,816,600
Increase in authorized share				20,000,000	5,000,000
Replacement Warrants, outstanding	1,257,331		559,905								17,631
Fair value modification of warrants recorded as stock issuance costs								2,112,800
Common share authorized capital increase				30,000,000	20,000,000							15,000,000
Offering price		$ 5.50				$ 4.75				$ 4.75	$ 0.05
Proceeds from common stock	$ 7,000,000	$ 3,000,000				$ 7,580,400	0	6,283,200	3,000,000
Addition proceed from common stock										$ 9,500,000
Issuence and sold aggregate shares of common stock and warrants	3,500,000	545,456				797,940				2,000,000
Additional common stock purchased		274,727								999,993
Issuance cost		$ 272,800					$ 0	$ 532,000	$ 272,800	$ 1,300,000
Exercisable price				$ 0.05		$ 9.50				$ 9.50	$ 2.00
Issuence and sold aggregate shares to investors						1,595,880
Common share authorized							20,000,000	30,000,000	20,000,000
Underwriter Warrants
Number of Warrant Issued								100,000
General and administrative								$ 161,000
Weighted Average Exercise Price Issued								$ 2.50
2012 Stock Option Plan (the "2012 Plan")
Increase in authorized share					943,000
Additional common stock purchased					150,000
Issuance of shares					1,750,000
Common share authorized					1,250,000							307,000
2023 Securities Purchase Agreement
Securities Purchase Agreement, Description	the Company issued and sold an aggregate of 2,638,076 Units, comprised of 2,638,076 shares of the Company’s common stock and Warrants to purchase 3,673,076 Warrant Shares for a total consideration of $5,276,152 pursuant to the Company’s 2023 Purchase Agreement. The Company recognized $970,200 of issuance cost, which includes $427,500 attributable to legal and placement agent fees and $542,700 attributable to the fair value of 131,904 warrants, issued to the private placement agent, to purchase up to 131,904 shares of Common Stock at an exercise price of $2.00 per share on substantially the same terms as the Warrants issued to the Investors		the Company sold an aggregate of 432,935 and 70,601 Units, respectively, comprised of 432,935 and 70,601 shares of the Company’s Common Stock and Warrants to purchase 432,935 and 70,601 shares of Common Stock for a total consideration of $865,870 and $141,202, respectively, pursuant to the Company’s 2023 Purchase Agreement. The Company recognized $206,900 of issuance cost, which includes $104,500 attributable to legal and placement agent fees and $102,400 attributable to the fair value of 25,177 warrants, issued to the private placement agent, to purchase up to 25,177 shares of Common Stock at an exercise price of $2.00 per share on substantially the same terms as the Warrants issued to the Investors